Further studies, particularly follow-up studies to examine whether ACE2 fragments levels are restored in patients after recovery, are needed, as well in vitro studies designed to understand the molecular mechanisms underpinning this severe neurological complication of COVID-19. The gene discussed is ACE2; the disease is COVID-19.